
MicroVision and Profusa Regain Nasdaq Listing Compliance
Medical technology firms MicroVision and Profusa have successfully met Nasdaq’s continued listing standards, reversing previous delisting risks. The regulatory compliance updates have stabilized their stock valuations and restored full trading privileges on the exchange.